Renal Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2013-06-17
  Clinical Trial Update: Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 3]

  Phase 3 trial evaluating interleukin-2 for metastatic renal cell carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2013-06-12
  Clinical Trial Update: Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer [Phase 3]

  A Phase 3 trial sponsored by the European Organisation for Research and Treatment of Cancer compared kidney-sparing surgery with radical nep…

• CLINICAL_TRIALS trial_result · 2013-06-10
  Clinical Trial Update: DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC [Phase 2]

  Phase 2 clinical trial evaluating a dendritic cell vaccine with IL-2 and interferon-alpha-2a in metastatic renal cell carcinoma. Results wer…

• CLINICAL_TRIALS trial_result · 2013-06-05
  Clinical Trial Update: Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]

  Phase 2 trial of ispinesib in metastatic or unresectable renal cell carcinoma has completed, reporting results in patients with recurrent or…

• CLINICAL_TRIALS trial_result · 2013-06-05
  Clinical Trial Update: PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer [Phase 2]

  A Phase 2 clinical trial evaluating PEG-Interferon alfa-2b in patients with metastatic kidney cancer has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2013-06-04
  Clinical Trial Update: Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects [Phase 3]

  Phase 3 trial comparing bevacizumab plus temsirolimus versus bevacizumab plus interferon-alfa in advanced renal cell carcinoma. Results were…

• CLINICAL_TRIALS trial_result · 2013-05-30
  Clinical Trial Update: Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma [Phase 1]

  Phase 1 study evaluating the combination of metformin and temsirolimus in patients with metastatic or unresectable solid tumors or lymphoma;…

• CLINICAL_TRIALS withdrawal · 2013-05-23
  Clinical Trial Update: Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma [Phase 2]

  Phase 2 trial of interferon alfa-2b (Intron A) for metastatic or unresectable clear cell renal cell carcinoma has been withdrawn.

• CLINICAL_TRIALS trial_result · 2013-05-22
  Clinical Trial Update: Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) [Phase 1]

  This Phase 1 trial of MDX-1203 in patients with clear cell renal cell carcinoma and relapsed/refractory B-cell non-Hodgkin lymphoma has comp…

• CLINICAL_TRIALS trial_result · 2013-05-22
  Clinical Trial Update: Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer [EARLY_Phase 1]

  A Phase 1 pilot study evaluating denileukin diftitox in combination with high-dose interleukin-2 for metastatic renal cell carcinoma has com…

• CLINICAL_TRIALS trial_result · 2013-05-14
  Clinical Trial Update: Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. [Phase 1]

  Phase 1 study of MDX-1411 given every 14 days with pre-medications in clear cell renal cell carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2013-05-13
  Clinical Trial Update: Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2 [Phase 2]

  Phase 2 trial update reporting safety and efficacy results for ABX-EGF in patients with advanced renal cell carcinoma.

• CLINICAL_TRIALS trial_result · 2013-05-13
  Clinical Trial Update: Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

  A completed clinical trial analyzing the incidence, prevalence, and symptom burden of advanced renal cell carcinoma in a commercially insure…

• CLINICAL_TRIALS research · 2013-05-13
  Clinical Trial Update: Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

  This is a completed clinical trial update examining the incidence, prevalence, and symptom burden of advanced renal cell carcinoma in a comm…

• CLINICAL_TRIALS trial_result · 2013-05-03
  Clinical Trial Update: Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]

  Phase 1 trial evaluating temsirolimus and bryostatin-1 in patients with unresectable or metastatic solid tumors, including recurrent melanom…

• CLINICAL_TRIALS research · 2013-05-03
  Clinical Trial Update: Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery [Phase 1]

  Phase 1 clinical study evaluating the combination of azacitidine and recombinant interferon alfa-2b in patients with unresectable stage III/…

• CLINICAL_TRIALS withdrawal · 2013-05-01
  Clinical Trial Update: A Post Marketing Surveillance As Required By Philippine Food And Drug Administration

  Pfizer-sponsored post-marketing surveillance study for renal cell carcinoma has been withdrawn.

• CLINICAL_TRIALS trial_result · 2013-04-15
  Clinical Trial Update: Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

  A terminated clinical trial evaluated whether Sorafenib or Regorafenib affects P63 expression and keratinocyte differentiation in human skin…

• CLINICAL_TRIALS trial_result · 2013-04-10
  Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]

  Phase 1 study of Alvespimycin hydrochloride in patients with metastatic or unresectable solid tumors has been completed, evaluating safety a…

• CLINICAL_TRIALS withdrawal · 2013-04-08
  Clinical Trial Update: Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) [Phase 2]

  A Phase 2 trial investigating Everolimus in combination with Sorafenib or Sunitinib for metastatic renal cell carcinoma has been withdrawn.

• CLINICAL_TRIALS trial_result · 2013-03-26
  Clinical Trial Update: RPI.4610 in Treating Patients With Metastatic Kidney Cancer [Phase 2]

  Phase 2 trial update showing RPI.4610 in metastatic renal cell carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2013-03-26
  Clinical Trial Update: Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [Phase 2]

  A phase 2 clinical trial evaluating a biological therapy after chemotherapy and peripheral stem cell transplantation in patients with variou…

• CLINICAL_TRIALS trial_result · 2013-03-25
  Clinical Trial Update: Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer [Phase 2]

  This clinical trial investigates ixabepilone for metastatic, recurrent, or unresectable renal cell carcinoma in a Phase 2 study; the trial h…

• CLINICAL_TRIALS trial_result · 2013-03-21
  Clinical Trial Update: Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma [Phase 1]

  Phase 1 clinical trial evaluating the combination of Interleukin-12 and Interferon alfa in patients with metastatic renal cell carcinoma and…

• CLINICAL_TRIALS trial_result · 2013-03-18
  Clinical Trial Update: Zoledronate With Atorvastatin in Renal Cell Carcinoma [Phase 2]

  Phase 2 trial assessing the combination of zoledronate and atorvastatin in renal cell carcinoma; results have been posted.